Glavonoid ruling allows weight loss use

By John Wood

- Last updated on GMT

European Commission ruling on use of liquorice root extract Glavonoid
European Commission ruling on use of liquorice root extract Glavonoid

Related tags: Nutrition

More products tackling visceral fat are likely to be developed, following a European Commission (EC) ruling on the use of the liquorice root extract Glavonoid.

That is the claim by Kaneka Pharma Europe, which developed the novel food ingredient, and has secured extended use approval from the EC.

Besides being used in food supplements and beverages based on milk, yogurt, fruit and vegetables, as accredited by its Novel Food status since 2011, Glavonoid can now also be applied in foods intended for medical purposes and energy-restricted diets for weight reduction.

Kaneka says that Glavenoid has been shown to both increase the body’s fat burning ability and to decrease fat development. In addition, it says, Glavonoid may also optimise cholesterol and blood glucose levels.

“Promising market potential”

Peter Lambrechts, business development manager at Kaneka’s Quality of Life division, who managed the approval process, said: “With visceral fat being the main risk factor for the development of metabolic syndromes and other chronic diseases such as cardiovascular illnesses, we see extremely promising market potential here.

​The new regulatory status for Glavonoid paves the way for manufacturers to create new products targeting markets such as weight management and body shaping.”

Related news

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars